Core Laboratories N.V.
CLBFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
524
Cost of Revenue
435
Gross Profit
88
Gross Margin
16.9%
Operating Income
59
Operating Margin
11.2%
Net Income
31
Net Margin
6.0%
EPS (Basic)
$0.67
EPS (Diluted)
$0.66
EBITDA
73
EBITDA Margin
14.0%
2023
12/31/2023
Revenue
510
Cost of Revenue
416
Gross Profit
94
Gross Margin
18.4%
Operating Income
55
Operating Margin
10.7%
Net Income
37
Net Margin
7.2%
EPS (Basic)
$0.79
EPS (Diluted)
$0.77
EBITDA
70
EBITDA Margin
13.8%
2022
12/31/2022
Revenue
490
Cost of Revenue
411
Gross Profit
79
Gross Margin
16.1%
Operating Income
42
Operating Margin
8.5%
Net Income
19
Net Margin
4.0%
EPS (Basic)
$0.42
EPS (Diluted)
$0.42
EBITDA
59
EBITDA Margin
12.0%
2021
12/31/2021
Revenue
470
Cost of Revenue
386
Gross Profit
84
Gross Margin
17.8%
Operating Income
45
Operating Margin
9.6%
Net Income
20
Net Margin
4.2%
EPS (Basic)
$0.43
EPS (Diluted)
$0.42
EBITDA
64
EBITDA Margin
13.6%
2020
12/31/2020
Revenue
487
Cost of Revenue
385
Gross Profit
102
Gross Margin
21.0%
Operating Income
-77
Operating Margin
-15.8%
Net Income
-98
Net Margin
-20.0%
EPS (Basic)
$-2.18
EPS (Diluted)
$-2.16
EBITDA
70
EBITDA Margin
14.5%